The Dow Jones (DJIA) is trading higher on Tuesday, driven by a higher-than-expected gross domestic product (GDP) print. U.S. GDP climbed by 4.3% …
Author: techrossm
Stock Market Today, Dec. 23: Novo Nordisk Surges After FDA Approves Oral Wegovy Weight Loss Pill
On Dec. 23, 2025, investors weighed a newly approved oral obesity pill’s first-mover edge and its ripple effects across healthcare.
Stock Market Live December 23: S&P 500 (VOO) Pops on Strong GDP Report
This article will be updated throughout the day, so check back often for more daily updates. The Vanguard S&P 500 ETF (NYSEMKT: VOO) is
Stock market today: S&P 500 eyes record high; analyst names Reddit 2026 top pick (live coverage)
The Dow Jones index rises Tuesday on surprise Q3 GDP data. Novo stock soared on FDA approval for a weight loss pill.
Stock market today: Dow edges up; J&J faces order to pay $1.5 billion in talc lawsuit (live coverage)
The Dow Jones index rises Tuesday on surprise Q3 GDP data. Novo stock soared on FDA approval for a weight loss pill.
Novo Nordisk stock jumps over 7% after weight loss drug Wegovy pill gets US FDA nod — Details here
Stock market news: Denmark-based pharmaceutical giant, Novo Nordisk, stock price jumped more than 7% during the stock market session on Tuesday, 23 December 2025,
Broadcom (AVGO) stock options are signaling pensiveness. Here’s why the fear might be unwarranted.
With fears of a bubble brewing in artificial intelligence consistently wreaking havoc on tech players in the fourth (calendar) quarter, semiconductor and software giant
Stock market today: Nasdaq leads after GDP surprise; solar stock dives (live coverage)
The Dow Jones index rises Tuesday on surprise Q3 GDP data. Novo stock soared on FDA approval for a weight loss pill.
Stock market today: Nasdaq leads after GDP surprise; solar stock dives (live coverage)
The Dow Jones index rises Tuesday on surprise Q3 GDP data. Novo stock soared on FDA approval for a weight loss pill.
Is IonQ Poised to Be the Quantum Stock Worth $50 Billion in 5 Years?
When taking into account its business, financials, and the stock price behavior of IonQ and its peers, one cannot count out the possibility of